Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 407

1.

Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.

Wesolowski R, Sharma N, Reebel L, Rodal MB, Peck A, West BL, Marimuthu A, Severson P, Karlin DA, Dowlati A, Le MH, Coussens LM, Rugo HS.

Ther Adv Med Oncol. 2019 Jun 21;11:1758835919854238. doi: 10.1177/1758835919854238. eCollection 2019.

2.

Sjogren's Syndrome and TAM Receptors: A Possible Contribution to Disease Onset.

Witas R, Peck AB, Ambrus JL, Nguyen CQ.

J Immunol Res. 2019 May 13;2019:4813795. doi: 10.1155/2019/4813795. eCollection 2019. Review.

3.

Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.

Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ.

Breast Cancer Res Treat. 2019 Aug;177(1):77-91. doi: 10.1007/s10549-019-05307-8. Epub 2019 Jun 4.

PMID:
31165373
4.

Connecting Student Employment and Leadership Development.

Peck A, Callahan K.

New Dir Stud Leadersh. 2019 Jun;2019(162):9-22. doi: 10.1002/yd.20330.

PMID:
31066506
5.

Editors' Notes.

Peck A, Callahan K.

New Dir Stud Leadersh. 2019 Jun;2019(162):5-8. doi: 10.1002/yd.20329. No abstract available.

PMID:
31066502
6.

Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment.

Vivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, Shafer B, Peck A, Sivils K, Rasmussen A, Chiorini JA, He J, Ambrus JL Jr.

Clin Immunol. 2019 Jun;203:81-121. doi: 10.1016/j.clim.2019.04.009. Epub 2019 Apr 29. Review. No abstract available.

PMID:
31022578
7.

Seborrheic keratosis-like lesions localized to tattoo.

Bakke JR, McMurray SL, Peck ASH, Fisher KR, Tyring SK, Rady PL, Patel TS, Jones A.

JAAD Case Rep. 2019 Mar 1;5(3):274-276. doi: 10.1016/j.jdcr.2019.01.017. eCollection 2019 Mar. No abstract available.

8.

Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner.

Harlow ML, Chasse MH, Boguslawski EA, Sorensen KM, Gedminas JM, Kitchen-Goosen SM, Rothbart SB, Taslim C, Lessnick SL, Peck AS, Madaj ZB, Bowman MJ, Grohar PJ.

Clin Cancer Res. 2019 Jun 1;25(11):3417-3429. doi: 10.1158/1078-0432.CCR-18-3511. Epub 2019 Feb 5.

PMID:
30723142
9.

Social Worker Integrated Care Competencies Scale (SWICCS): Assessing social worker clinical competencies for health care settings.

Davis TS, Reno R, Guada J, Swenson S, Peck A, Saunders-Adams S, Haas-Gehres L.

Soc Work Health Care. 2019 Jan;58(1):75-92. doi: 10.1080/00981389.2018.1547346. Epub 2018 Nov 20.

PMID:
30457040
10.

Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells.

Gennaro VJ, Stanek TJ, Peck AR, Sun Y, Wang F, Qie S, Knudsen KE, Rui H, Butt T, Diehl JA, McMahon SB.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9298-E9307. doi: 10.1073/pnas.1807704115. Epub 2018 Sep 17.

11.

Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy.

Spangler JB, Trotta E, Tomala J, Peck A, Young TA, Savvides CS, Silveria S, Votavova P, Salafsky J, Pande VS, Kovar M, Bluestone JA, Garcia KC.

J Immunol. 2018 Oct 1;201(7):2094-2106. doi: 10.4049/jimmunol.1800578. Epub 2018 Aug 13.

PMID:
30104245
12.

Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.

Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H.

Clin Cancer Res. 2018 Dec 15;24(24):6355-6366. doi: 10.1158/1078-0432.CCR-17-3280. Epub 2018 Aug 10.

PMID:
30097435
13.

Adult Henolch-Schonlein purpura: multiorgan failure in the setting of a purpuric rash.

Maxfield L, Peck A, Youngblood LB.

BMJ Case Rep. 2018 Aug 9;2018. pii: bcr-2018-224816. doi: 10.1136/bcr-2018-224816.

PMID:
30093466
14.

A Multidisciplinary Approach to Equipment Use in Pediatric Patient Mobilization.

Parchem K, Peck A, Tales K.

Crit Care Nurs Q. 2018 Jul/Sep;41(3):330-339. doi: 10.1097/CNQ.0000000000000211.

PMID:
29851684
15.

Intermolecular correlations are necessary to explain diffuse scattering from protein crystals.

Peck A, Poitevin F, Lane TJ.

IUCrJ. 2018 Feb 21;5(Pt 2):211-222. doi: 10.1107/S2052252518001124. eCollection 2018 Mar 1.

16.

Mapping Career-Ready Skills Through Student Leadership Programs.

Peck A.

New Dir Stud Leadersh. 2018 Mar;2018(157):71-83. doi: 10.1002/yd.20280.

PMID:
29451737
17.

CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion.

Jiao X, Velasco-Velázquez MA, Wang M, Li Z, Rui H, Peck AR, Korkola JE, Chen X, Xu S, DuHadaway JB, Guerrero-Rodriguez S, Addya S, Sicoli D, Mu Z, Zhang G, Stucky A, Zhang X, Cristofanilli M, Fatatis A, Gray JW, Zhong JF, Prendergast GC, Pestell RG.

Cancer Res. 2018 Apr 1;78(7):1657-1671. doi: 10.1158/0008-5472.CAN-17-0915. Epub 2018 Jan 22.

18.

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.

Yeshurun M, Vaxman I, Shargian L, Yahav D, Bishara J, Pasvolsky O, Wolach O, Lahav M, Gurion R, Magen H, Vidal L, Herscovici C, Peck A, Moshe M, Sela-Navon M, Naparstek E, Raanani P, Rozovski U.

Clin Microbiol Infect. 2018 Jul;24(7):749-754. doi: 10.1016/j.cmi.2017.11.019. Epub 2017 Dec 6.

19.

Re-Framing Biotechnology Regulation.

Peck A.

Food Drug Law J. 2017;72(2):314-40.

PMID:
29140662
20.

Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth.

Pestell TG, Jiao X, Kumar M, Peck AR, Prisco M, Deng S, Li Z, Ertel A, Casimiro MC, Ju X, Di Rocco A, Di Sante G, Katiyar S, Shupp A, Lisanti MP, Jain P, Wu K, Rui H, Hooper DC, Yu Z, Goldman AR, Speicher DW, Laury-Kleintop L, Pestell RG.

Oncotarget. 2017 Aug 4;8(47):81754-81775. doi: 10.18632/oncotarget.19953. eCollection 2017 Oct 10.

21.

Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin.

Waldhart AN, Dykstra H, Peck AS, Boguslawski EA, Madaj ZB, Wen J, Veldkamp K, Hollowell M, Zheng B, Cantley LC, McGraw TE, Wu N.

Cell Rep. 2017 Jun 6;19(10):2005-2013. doi: 10.1016/j.celrep.2017.05.041.

22.

What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?

Peck AB, Nguyen CQ.

Clin Immunol. 2017 Sep;182:14-23. doi: 10.1016/j.clim.2017.05.001. Epub 2017 May 3. Review.

23.

First in vivo traumatic brain injury imaging via magnetic particle imaging.

Orendorff R, Peck AJ, Zheng B, Shirazi SN, Matthew Ferguson R, Khandhar AP, Kemp SJ, Goodwill P, Krishnan KM, Brooks GA, Kaufer D, Conolly S.

Phys Med Biol. 2017 May 7;62(9):3501-3509. doi: 10.1088/1361-6560/aa52ad. Epub 2017 Apr 5.

24.

Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.

Katlinski KV, Gui J, Katlinskaya YV, Ortiz A, Chakraborty R, Bhattacharya S, Carbone CJ, Beiting DP, Girondo MA, Peck AR, Puré E, Chatterji P, Rustgi AK, Diehl JA, Koumenis C, Rui H, Fuchs SY.

Cancer Cell. 2017 Feb 13;31(2):194-207. doi: 10.1016/j.ccell.2017.01.004.

25.

Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles.

Li S, Johnson J, Peck A, Xie Q.

J Transl Med. 2017 Jan 23;15(1):18. doi: 10.1186/s12967-016-1115-2.

26.

Establishment of Personalized Pain Goals in Oncology Patients to Improve Care and Decrease Costs.

Zylla D, Larson A, Chuy G, Illig L, Peck A, Van Peursem S, Fulbright JW, Pawloski PA, Richter S, Mettner J.

J Oncol Pract. 2017 Mar;13(3):e266-e272. doi: 10.1200/JOP.2016.017616. Epub 2017 Jan 3.

PMID:
28045611
27.

Cell cycle and growth stimuli regulate different steps of RNA polymerase I transcription.

Hung SS, Lesmana A, Peck A, Lee R, Tchoubrieva E, Hannan KM, Lin J, Sheppard KE, Jastrzebski K, Quinn LM, Rothblum LI, Pearson RB, Hannan RD, Sanij E.

Gene. 2017 May 15;612:36-48. doi: 10.1016/j.gene.2016.12.015. Epub 2016 Dec 15.

PMID:
27989772
28.

Medication Palatability Affects Physician Prescribing Preferences for Common Pediatric Conditions.

Bradshaw H, Mitchell MJ, Edwards CJ, Stolz U, Naser O, Peck A, Patanwala AE.

Acad Emerg Med. 2016 Nov;23(11):1243-1247. doi: 10.1111/acem.13020. Epub 2016 Oct 31.

29.

Multiple Roles for B-Lymphocytes in Sjogren's Syndrome.

Ambrus JL, Suresh L, Peck A.

J Clin Med. 2016 Oct 8;5(10). pii: E87. Review.

30.

18F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma.

Osgood CL, Tantawy MN, Maloney N, Madaj ZB, Peck A, Boguslawski E, Jess J, Buck J, Winn ME, Manning HC, Grohar PJ.

Sci Rep. 2016 Sep 27;6:33926. doi: 10.1038/srep33926.

31.

Corrigendum: Conformational heterogeneity of the calmodulin binding interface.

Shukla D, Peck A, Pande VS.

Nat Commun. 2016 Aug 10;7:12318. doi: 10.1038/ncomms12318. No abstract available.

32.

Carts Before Horses? Remembering the Primacy of the Student's Experience in Student Learning.

Preston M, Peck A.

New Dir Stud Leadersh. 2016 Sep;2016(151):79-91. doi: 10.1002/yd.20202.

PMID:
27502099
33.

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.

Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H.

Mod Pathol. 2016 Oct;29(10):1143-54. doi: 10.1038/modpathol.2016.112. Epub 2016 Jun 17.

34.

Second Epoch VLBA Calibrator Survey Observations - VCS-II.

Gordon D, Jacobs C, Beasley A, Peck A, Gaume R, Charlot P, Fey A, Ma C, Titov O, Boboltz D.

Astron J. 2016 May 27;151(6). pii: 154. doi: 10.3847/0004-6256/151/6/154.

35.

Compliance issues in marketing physician practices.

Peck AA.

J Med Assoc Ga. 2016;105(1):30. No abstract available.

PMID:
27209679
36.

Tungstate as a Transition State Analog for Catalysis by Alkaline Phosphatase.

Peck A, Sunden F, Andrews LD, Pande VS, Herschlag D.

J Mol Biol. 2016 Jul 3;428(13):2758-68. doi: 10.1016/j.jmb.2016.05.007. Epub 2016 May 14.

37.

Making data work for your practice.

Peck AD.

Med Econ. 2016 Jan 25;93(2):42-3, 45-6, 48. No abstract available.

PMID:
27089797
38.

How Cerner deal could change the EHR market.

Peck AD.

Med Econ. 2016 Jan 10;93(1):44-6. No abstract available.

PMID:
27078912
39.

Conformational heterogeneity of the calmodulin binding interface.

Shukla D, Peck A, Pande VS.

Nat Commun. 2016 Apr 4;7:10910. doi: 10.1038/ncomms10910. Erratum in: Nat Commun. 2016 Aug 10;7:12318.

40.

Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis.

Gao W, Emaminejad S, Nyein HYY, Challa S, Chen K, Peck A, Fahad HM, Ota H, Shiraki H, Kiriya D, Lien DH, Brooks GA, Davis RW, Javey A.

Nature. 2016 Jan 28;529(7587):509-514. doi: 10.1038/nature16521.

41.

Integrated and Culturally Relevant Care: A Model to Prepare Social Workers for Primary Care Behavioral Health Practice.

Davis TS, Guada J, Reno R, Peck A, Evans S, Sigal LM, Swenson S.

Soc Work Health Care. 2015;54(10):909-38. doi: 10.1080/00981389.2015.1062456.

PMID:
26671244
42.

Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?

Peck AB, Canales BK, Nguyen CQ.

Urolithiasis. 2016 Feb;44(1):45-50. doi: 10.1007/s00240-015-0845-6. Epub 2015 Dec 8. Review.

PMID:
26645869
43.

Find the right EHR for your practice.

Peck AD.

Med Econ. 2015 Oct 25;92(20):54, 56, 58-9. No abstract available.

PMID:
26619630
44.

Csf2 and Ptgs2 Epigenetic Dysregulation in Diabetes-prone Bicongenic B6.NODC11bxC1tb Mice.

Garrigan E, Belkin NS, Seydel F, Han Z, Carter J, McDuffie M, Morel L, Peck AB, Clare-Salzler MJ, Atkinson M, Wasserfall C, Davoodi-Semiromi A, Shi JD, Haskell-Luevano C, Yang LJ, Alexander JJ, Cdebaca A, Piliant T, Riggs C, Amick M, Litherland SA.

Genet Epigenet. 2015 Oct 11;7:5-17. doi: 10.4137/GEG.S29696. eCollection 2015.

45.

High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia.

Shacham-Abulafia A, Itchaki G, Yeshurun M, Paul M, Peck A, Leader A, Shpilberg O, Ram R, Raanani P.

Acta Haematol. 2016;135(1):55-64. doi: 10.1159/000437131. Epub 2015 Oct 8.

PMID:
26443995
46.

A quantitative approach to assessing the efficacy of occupant protection programs: A case study from Montana.

Manlove K, Stanley L, Peck A.

Accid Anal Prev. 2015 Oct;83:214-21. doi: 10.1016/j.aap.2015.06.009.

PMID:
26310801
47.

(99m)TC-Methylene diphosphonate uptake at injury site correlates with osteoblast differentiation and mineralization during bone healing in mice.

Zhong ZA, Peck A, Li S, VanOss J, Snider J, Droscha CJ, Chang TA, Williams BO.

Bone Res. 2015 Jun 9;3:15013. doi: 10.1038/boneres.2015.13. eCollection 2015.

48.

Optimize your patient portal.

Peck AD.

Med Econ. 2014 Sep 10;91(17):48-50, 52. No abstract available.

PMID:
26242096
49.

Modeling structural change in spatial system dynamics: A Daisyworld example.

Neuwirth C, Peck A, Simonović SP.

Environ Model Softw. 2015 Mar;65:30-40.

50.

Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.

Goodman CR, Sato T, Peck AR, Girondo MA, Yang N, Liu C, Yanac AF, Kovatich AJ, Hooke JA, Shriver CD, Mitchell EP, Hyslop T, Rui H.

Oncogene. 2016 Mar 17;35(11):1373-85. doi: 10.1038/onc.2015.193. Epub 2015 Jun 22.

Supplemental Content

Support Center